Forbes Features Longevity Medical Institute Founder & CEO, Dr. Kirk Sanford, on the Future of Peptide Oversight

As interest in peptides continues to expand, Forbes highlighted the importance of medical oversight, sourcing transparency, sterility, proper handling, dosing accuracy, and consumer education.

Dr. Sanford emphasized that patients are becoming more educated and proactive when considering peptide therapies. While weight loss remains a major area of interest, many patients are now asking about peptides for recovery, inflammation, sleep, cognition, body composition, aesthetics, healthy aging, and performance optimization.

He also discussed the growing demand for more convenient delivery systems, including reconstituted peptide pens with clear instructions and accurate dosing. However, Dr. Sanford cautioned that convenience must be matched with proper medical standards.

“Peptides are sensitive biologic products,” Dr. Sanford explained in the Forbes article. “Where they come from, how they are stored, how they are reconstituted, and how accurately they are dosed all matter.”

At Longevity Medical Institute, peptide therapy is approached through a physician-led model focused on evaluation, safety, proper sourcing, and individualized treatment planning. Patients should understand whether third-party testing exists, whether Certificates of Analysis are available, whether products are prepared in sterile environments, and whether dosing and storage protocols are clearly managed.

Dr. Sanford also stressed that peptides should not be treated like ordinary supplements. Because peptides may influence biologic pathways, they should be considered within the context of a patient’s medical history, current health status, diagnostic findings, and specific goals.

“A proper medical evaluation and diagnostic work-up should be done first,” Dr. Sanford said. “In order to get meaningful results, you need to know what you are actually treating or trying to optimize.”

As peptides become more mainstream, Longevity Medical Institute believes the future of the field will depend on transparency, medical oversight, product quality, and patient education. For patients exploring peptide therapy, the key question is not simply whether peptides may be beneficial, but whether they are being used responsibly, safely, and under appropriate clinical guidance.

Patients interested in peptide therapy, longevity medicine, or personalized health optimization can schedule a consultation with Longevity Medical Institute to determine whether peptide-based protocols may be appropriate for their individual needs.

Read the full Forbes feature to learn more about Dr. Sanford’s opinion on the importance of peptide oversight.